Patents by Inventor Robert Vukovich

Robert Vukovich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8178664
    Abstract: A method of preparing metal mesoporphyrin halide compounds is described. The metal mesoporphyrin halide compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to the metal mesoporphyrin halide through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: May 15, 2012
    Assignee: Infacare Pharmaceutical Corporation
    Inventors: Robert Vukovich, Benjamin Levinson, George S. Drummond, Robert Caroselli, Kazimierz G. Antczak, Christopher Boucher, Richard Mortimer, Danny Levin, Keith A. Cooke
  • Publication number: 20100280237
    Abstract: A method of preparing metal mesoporphyrin halide compounds is described. The metal mesoporphyrin halide compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to the metal mesoporphyrin halide through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery.
    Type: Application
    Filed: July 9, 2010
    Publication date: November 4, 2010
    Inventors: Robert Vukovich, Benjamin Levinson, George S. Drummond, Robert Caroselli, R.ph, Kazimierz G. Antczak, Christopher Boucher, Richard Mortimer, Danny Levin, Keith A. Cooke
  • Patent number: 7777028
    Abstract: A method of preparing metal mesoporphyrin halide compounds is described. The metal mesoporphyrin halide compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to the metal mesoporphyrin halide through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: August 17, 2010
    Assignee: Infacare Pharmaceutical Corporation
    Inventors: Robert A. Vukovich, Benjamin Levinson, George S. Drummond, Robert Caroselli, Kazimierz G. Antczak, Christopher P. Boucher, Richard Mortimer, Daniel Levin, Keith A. Cooke
  • Publication number: 20080154033
    Abstract: A method of preparing metal mesoporphyrin halide compounds is described. The metal mesoporphyrin halide compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to the metal mesoporphyrin halide through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery.
    Type: Application
    Filed: December 14, 2007
    Publication date: June 26, 2008
    Inventors: Robert Vukovich, Benjamin Levinson, George S. Drummond, Robert Caroselli, Kazimierz G. Antczak, Christopher Boucher, Richard Mortimer, Danny Levin, Keith A. Cooke
  • Patent number: 7375216
    Abstract: A method of preparing metal mesoporphyrin compounds is described. A metal mesoporphyrin compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to a metal mesoporphyrin compound through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery.
    Type: Grant
    Filed: March 29, 2004
    Date of Patent: May 20, 2008
    Assignee: InfaCare Pharmaceutical Corporation
    Inventors: Robert Vukovich, Benjamin Levinson, George S. Drummond, Robert Caroselli, Kazimierz G. Antczak, Christopher Boucher, Richard Mortimer, Danny Levin, Keith A. Cooke
  • Patent number: 6818763
    Abstract: A method of preparing metal mesoporphyrin halide compounds is described. The metal mesoporphyrin halide compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to the metal mesoporphyrin halide through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: November 16, 2004
    Assignee: Wellspring Pharmaceutical Corporation
    Inventors: Robert A. Vukovich, Benjamin Levinson, George S. Drummond, Robert Caroselli, Kazimierz G. Antczak, Christopher Boucher, Richard Mortimer
  • Publication number: 20040210048
    Abstract: A method of preparing metal mesoporphyrin halide compounds is described. The metal mesoporphyrin halide compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to the metal mesoporphyrin halide through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery.
    Type: Application
    Filed: March 29, 2004
    Publication date: October 21, 2004
    Applicant: WellSpring Pharmaceutical Corporation
    Inventors: Robert Vukovich, Benjamin Levinson, George S. Drummond, Robert Caroselli, Kazimierz G. Antczak, Christopher Boucher, Richard Mortimer, Danny Levin, Keith A. Cooke
  • Publication number: 20030225264
    Abstract: A method of preparing metal mesoporphyrin halide compounds is described. The metal mesoporphyrin halide compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to the metal mesoporphyrin halide through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery.
    Type: Application
    Filed: June 3, 2003
    Publication date: December 4, 2003
    Inventors: Robert A. Vukovich, Benjamin Levinson, George S. Drummond, Robert Caroselli, Kazimierz G. Antczak, Christopher Boucher, Richard Mortimer